15 Eckstein A, Quadbeck B, Mueller G, Rettenmeier AW, Hoermann R, Mann K, Steuhl P, Esser J. Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol ,2003;87:773-776

16 Zhang DW, Ma T, Luo Y, Wang X. High-dose corticostepoid therapy for 26 patients with seveve thyvoid associated Ophthalmopathy. Int J Ophthalmol(Guoji Yanke Zazhi) ,2003;3(4):122-123

17 Kazatchkine MD, Kaveri SV.Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med ,2001;345(10):747-755

18 Kahaly G, Pitz S, Muller-Forell W, Hommel G. Randomized trial of intravenous immunoglobulins versus prednisolone in Graves'ophthalmopathy.Clin Exp Immunol ,1996;106(2):197-220

19 Ferone D, Arvigo M, Semino C, Jaquet P, Saveanu A, Taylor JE, Moreau JP, Culler MD, Albertelli M, Minuto F, Barreca A. Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.Am J Physiol Endocrinol Metab. 2005;289(6):1044-1050

20 Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev ,2000;21(2):168-199

21 Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet ,1993;342(8877):949-954

22 Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab ,2001;86(8):3562-3567

23 Stabile JR, Trokel SM. Increase in orbital volume obtained by decompression in dried skulls. Am J Ophthalmol ,1983;95(3):327-331

24 Lantz M, Vondrichova T, Parikh H, Frenander C, Ridderstrale M, Asman P, Aberg M, Groop L, Hallengren B. Overexpression of immediate early genes in active Graves' Ophthalmopathy.J Clin Endocrinol Metab ,2005;90(8):4784-4791

25 Unal M, Leri F, Konuk O, Hasanreisoglu B. Balanced orbital decompression combined with fat removal in Graves ophthalmopathy: do we really need to remove the third wall? Ophthal Plast Reconstr Surg ,2003;19(2):112-118

26 Ben Simon GJ, Schwarcz RM, Mansury AM, Wang L, McCann JD, Goldberg RA. Minimally invasive orbital decompression: local anesthesia and hand-carved bone.Arch Ophthalmol ,2005;123(12):1671-1675

27 Mourits MP, Koorneef L, van Mourik-Noordenbos AM, van der Meulen-Schot HM, Prummel MF, Wiersinga WM, Berghout A. Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome? Br J Ophthalmol ,1990;74(8):481-483

28 Schussler-Fiorenza CM, Bruns CM, Chen H. The Surgical Management of Graves' Disease. J Surg Res ,2006;2 [Epub ahead of print]

29 Zhu XB, Pang YJ, Bao JL, Li Q. Surgical treatment of superior eyelid retraction of thyroid associated Ophthalmopathy. Int J Ophthalmol(Guoji Yanke Zazhi) ,2005;5(3):487-489

30 Bartalena L, Marcocci C, Tanda ML, Piantanida E, Lai A, Marino M, Pinchera A. An update on medical management of Graves' ophthalmopathy.J Endocrinol Invest ,2005;28(5):469-478.

上一页  [1] [2] [3] [4] [5] [6]